JPS57118560A - Preparation of 1-sulfo-2-oxoazetidine and its intermediate - Google Patents
Preparation of 1-sulfo-2-oxoazetidine and its intermediateInfo
- Publication number
- JPS57118560A JPS57118560A JP56194319A JP19431981A JPS57118560A JP S57118560 A JPS57118560 A JP S57118560A JP 56194319 A JP56194319 A JP 56194319A JP 19431981 A JP19431981 A JP 19431981A JP S57118560 A JPS57118560 A JP S57118560A
- Authority
- JP
- Japan
- Prior art keywords
- compound shown
- oxoazetidine
- isopropylsilyl
- formulai
- acylated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CDFGMYLBUSYTKQ-UHFFFAOYSA-N 2-oxoazetidine-1-sulfonic acid Chemical compound OS(=O)(=O)N1CCC1=O CDFGMYLBUSYTKQ-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- -1 isopropylsilyl compound Chemical class 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 2
- 108090000204 Dipeptidase 1 Proteins 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 102000006635 beta-lactamase Human genes 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Inorganic materials O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 abstract 1
- 150000003952 β-lactams Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
- C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP1980/000293 WO1982001871A1 (en) | 1980-12-03 | 1980-12-03 | Process for preparing a 1-sulfo-2-oxoazetidine derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS57118560A true JPS57118560A (en) | 1982-07-23 |
Family
ID=13706129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56194319A Pending JPS57118560A (en) | 1980-12-03 | 1981-12-01 | Preparation of 1-sulfo-2-oxoazetidine and its intermediate |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0053387A1 (ja) |
| JP (1) | JPS57118560A (ja) |
| DK (1) | DK534281A (ja) |
| ES (1) | ES8303327A1 (ja) |
| WO (1) | WO1982001871A1 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3342929A1 (de) * | 1983-11-26 | 1985-06-05 | Bayer Ag, 5090 Leverkusen | Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel |
| US4883869A (en) * | 1984-12-20 | 1989-11-28 | The Upjohn Company | Novel beta-lactams containing amino acid substituents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU531084B2 (en) * | 1977-10-19 | 1983-08-11 | Merck & Co., Inc. | Azetidine derivatives |
| US4224336A (en) * | 1979-04-17 | 1980-09-23 | Merck & Co., Inc. | 3-(2-Aminoethylthio)-6-amido-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid |
| CA1338538C (en) * | 1979-06-08 | 1996-08-20 | Taisuke Matsuo | 1-sulfo-2-oxoazetidine derivatives and their production |
-
1980
- 1980-12-03 WO PCT/JP1980/000293 patent/WO1982001871A1/ja unknown
-
1981
- 1981-12-01 JP JP56194319A patent/JPS57118560A/ja active Pending
- 1981-12-01 EP EP81110039A patent/EP0053387A1/en not_active Withdrawn
- 1981-12-02 ES ES507638A patent/ES8303327A1/es not_active Expired
- 1981-12-02 DK DK564281A patent/DK534281A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES507638A0 (es) | 1983-02-01 |
| EP0053387A1 (en) | 1982-06-09 |
| DK534281A (da) | 1982-06-04 |
| WO1982001871A1 (en) | 1982-06-10 |
| ES8303327A1 (es) | 1983-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5756485A (en) | Cephem of penam compound and its preparation | |
| JPS57131759A (en) | 2-oxoazetidine derivative, its preparation and use | |
| JPS57176988A (en) | Penam-3-carboxylic acid derivative and its preparation | |
| JPS57131758A (en) | 1-sulfo-2-oxoazetidine derivative, its preparation and use | |
| JPS57118560A (en) | Preparation of 1-sulfo-2-oxoazetidine and its intermediate | |
| JPS55111463A (en) | Beta-lactam compound and its preparation | |
| JPS55164672A (en) | Azetidine derivative and its preparation | |
| JPS56142282A (en) | Penem-3-carboxylic acid derivative and its preparation | |
| JPS5798258A (en) | Beta-lactamase inhibitor composition | |
| JPS55164671A (en) | Azetidine derivative and its preparation | |
| JPS543090A (en) | Novel derivative of cephalosporin compound and its preparation | |
| JPS56115788A (en) | Azetidinone derivative and its preparation | |
| JPS5716856A (en) | 4-guanidinomethylcyclohexanecarboxylic acid ester and its preparation | |
| JPS56152476A (en) | Novel minimycin derivative | |
| JPS56133260A (en) | Azetidine derivative and its preparation | |
| JPS5630998A (en) | 1-n-(l-4-amino-2-hydroxybutyryl)derivative of 6'-c-alkyl-3'-deoxykanamycin b or 6'-c-alkyl-3',4-dideoxykanamycin b | |
| JPS56138180A (en) | Di-n6',o3-demethylistamycin a and its preparation | |
| JPS5616491A (en) | Cephalosporin analog | |
| JPS57120591A (en) | Novel penem derivative | |
| IE823036L (en) | Azetidinones. | |
| JPS57169452A (en) | Novel phenoxyalkylamide derivative | |
| JPS54115354A (en) | Biphenylylglycine derivative | |
| JPS5610198A (en) | Phosphonic acid derivative | |
| JPS5653678A (en) | Preparation of 1,10-phenanthroilnes | |
| JPS5770897A (en) | Aminoethylphosphonic acid derivative |